Therapeutic Asset Ratings
263 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Everolimus
Hepatocellular Carcinoma
Captor Therapeutics S.A.
P4
BB
(64)
Recombinant Human Adenovirus Type 5
Hepatocellular Carcinoma
Henan Cancer Hospital
P4
BB
(64)
CIS-DIAMMINEDICHLOROPLATINUM II
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
P3
BB
(64)
Pyrotinib
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(64)
rc48-adc
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(64)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Hepatocellular Carcinoma
Riboscience, LLC.
P4
B
(63)
Monomethyl Fumarate
Hepatocellular Carcinoma
Wondercel Biotech (ShenZhen)
P4
B
(63)
Catequentinib
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University
P3
B
(63)
Ipilimumab
Hepatocellular Carcinoma
University of Hawaii
P3
B
(63)
Toripalimab
Hepatocellular Carcinoma
Sun Yat-sen University
P3
B
(63)
DEXAMETHASONE
Hepatocellular Carcinoma
Shunda Du
P3
B
(62)
ibi310
Hepatocellular Carcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
P3
B
(62)
LOBAPLATIN
Hepatocellular Carcinoma
Zhujiang Hospital
P3
B
(62)
Regorafenib
Hepatocellular Carcinoma
University of Miami
P3
B
(62)
Entecavir
Hepatocellular Carcinoma
Sun Yat-sen University
P4
B
(61)
PROPRANOLOL
Hepatocellular Carcinoma
AHS Cancer Control Alberta
P4
B
(61)
TENOFOVIR DISOPROXIL FUMARATE
Hepatocellular Carcinoma
Ningbo No.2 Hospital
P4
B
(61)
Thalidomide
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
P3
B
(61)
Cetuximab
Hepatocellular Carcinoma
Sanofi
P2
B
(61)
PROPOFOL
Hepatocellular Carcinoma
Iuliu Hatieganu University of Medicine and Pharmacy
P4
B
(60)
2-CHLORO-N6-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE
Hepatocellular Carcinoma
Can-Fite BioPharma
P3
B
(60)
Adebrelimab
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University
P3
B
(60)
Anlotinib Hydrochloride Capsules
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
B
(60)
Benmelstobart
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University
P3
B
(60)
Capecitabine
Hepatocellular Carcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
P3
B
(60)
Showing 26 to 50 of 263 assets
Previous
Page 2 of 11
Next